The quest for treatment of cognitive impairment: AMPA and mGlu5 receptor modulators

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.18, Iss.9, 2008-09, pp. : 999-1010

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The quest for the treatment of cognitive impairment: α₇ nicotinic and α₅ GABA_A receptor modulators

By Romanelli Maria Novella Gualtieri Fulvio

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 11, 2007-11 ,pp. : 1365-1377

Informa Healthcare

Access to resources Recommend Favorite

SAR Studies on mGlu5 Receptor Positive Allosteric Modulators (2003- 2013)

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 15, 2014-08 ,pp. : 1789-1841

Bentham Science Publishers

Access to resources Recommend Favorite

mGlu₅ negative allosteric modulators: a patent review (2010 – 2012)

By Emmitte Kyle A

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 4, 2013-04 ,pp. : 393-408

Informa Healthcare

Access to resources Recommend Favorite

AMPA receptor modulators as cognitive enhancers

By Lynch G.

Current Opinion in Pharmacology, Vol. 4, Iss. 1, 2004-02 ,pp. : 4-11

Elsevier

Access to resources Recommend Favorite

Allosteric Modulators for mGlu Receptors

Current Neuropharmacology, Vol. 5, Iss. 3, 2007-09 ,pp. : 187-194

Bentham Science Publishers

Access to resources Recommend Favorite